Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues: |
License-based | | | | | | | 579.4 | 552.3 |
Asset-based | | | | | | | 163.6 | 163.6 |
Transaction-based | | | | | | | 55.6 | 72.9 |
Total revenues | 1,870.6 | 1,699.3 | 1,389.5 | 1,179.0 | 1,019.9 | 911.7 | 798.6 | 788.8 |
Revenue growth [+] | 10.1% | 22.3% | 17.9% | 15.6% | 11.9% | 14.2% | 1.2% | 3.8% |
License-based | | | | | | | 4.9% | 2.2% |
Asset-based | | | | | | | 0.0% | 5.6% |
Transaction-based | | | | | | | -23.7% | 12.2% |
Cost of goods sold | 779.3 | 698.4 | 556.4 | 483.1 | 411.1 | 386.6 | 344.3 | 330.1 |
Gross profit | 1,091.3 | 1,000.9 | 833.1 | 695.9 | 608.8 | 525.1 | 454.3 | 458.7 |
Gross margin | 58.3% | 58.9% | 60.0% | 59.0% | 59.7% | 57.6% | 56.9% | 58.2% |
Selling, general and administrative [+] | 756.9 | 593.2 | 478.4 | 388.6 | 296.3 | 264.1 | 202.8 | 203.7 |
Sales and marketing | 356.5 | 274.8 | 206.4 | 177.9 | 148.5 | 134.3 | 97.6 | 96.6 |
General and administrative | 400.4 | 318.4 | 272.0 | 210.7 | 147.8 | 129.8 | 105.2 | 107.1 |
Research and development | | | | | | | | |
Equity in earnings | 3.6 | -5.4 | -0.3 | 0.9 | 2.1 | 1.3 | -0.2 | 1.8 |
Other operating expenses | | | | | | -33.4 | | |
EBITDA [+] | 338.0 | 402.3 | 354.4 | 308.2 | 314.6 | 295.7 | 251.3 | 256.8 |
EBITDA growth | -16.0% | 13.5% | 15.0% | -2.0% | 6.4% | 17.7% | -2.1% | 15.9% |
EBITDA margin | 18.1% | 23.7% | 25.5% | 26.1% | 30.8% | 32.4% | 31.5% | 32.6% |
Depreciation | 99.9 | 88.7 | 80.7 | 81.2 | 76.0 | 67.6 | 51.3 | 42.4 |
EBITA | 238.1 | 313.6 | 273.7 | 227.0 | 238.6 | 228.1 | 200.0 | 214.4 |
EBITA margin | 12.7% | 18.5% | 19.7% | 19.3% | 23.4% | 25.0% | 25.0% | 27.2% |
Amortization of intangibles | 66.7 | 62.0 | 58.8 | 36.5 | 20.7 | 23.6 | 19.4 | 22.0 |
EBIT [+] | 171.4 | 251.6 | 214.9 | 190.5 | 217.9 | 204.5 | 180.6 | 192.4 |
EBIT growth | -31.9% | 17.1% | 12.8% | -12.6% | 6.6% | 13.2% | -6.1% | 15.5% |
EBIT margin | 9.2% | 14.8% | 15.5% | 16.2% | 21.4% | 22.4% | 22.6% | 24.4% |
Non-recurring items [+] | | | | | | 33.4 | | |
Loss (gain) on sale of assets | | | | | | 16.7 | | |
Loss (gain) on sale of business | | | | | | 16.7 | | |
Interest expense, net [+] | 28.4 | 8.7 | 9.5 | 8.7 | 1.8 | 3.6 | -0.3 | -1.3 |
Interest expense | 28.4 | 8.7 | 9.5 | 8.7 | 1.8 | 3.6 | | |
Interest income | | | | | | | 0.3 | 1.3 |
Other income (expense), net [+] | -12.4 | 7.6 | 77.6 | 16.7 | 16.8 | 13.6 | 44.0 | |
Gain (loss) on sale of assets | | 0.9 | 30.0 | 19.5 | 5.6 | | | |
Realized gain (loss) on investments | | | | | 1.0 | 3.2 | 0.6 | 0.6 |
Other | -6.7 | -3.7 | -5.7 | -3.1 | 1.8 | -5.0 | 6.1 | 5.3 |
Pre-tax income | 130.6 | 250.5 | 283.0 | 198.5 | 232.9 | 181.1 | 224.9 | 193.7 |
Income taxes | 56.5 | 62.6 | 59.7 | 45.6 | 47.8 | 42.9 | 63.7 | 62.7 |
Tax rate | 43.3% | 25.0% | 21.1% | 23.0% | 20.5% | 23.7% | 28.3% | 32.4% |
Minority interest | | | | | | | | 0.2 |
Net income | 70.5 | 193.3 | 223.6 | 152.0 | 183.0 | 136.9 | 161.0 | 132.6 |
Net margin | 3.8% | 11.4% | 16.1% | 12.9% | 17.9% | 15.0% | 20.2% | 16.8% |
|
Basic EPS [+] | $1.65 | $4.50 | $5.21 | $3.56 | $4.30 | $3.21 | $3.74 | $3.00 |
Growth | -63.2% | -13.8% | 46.4% | -17.1% | 34.0% | -14.4% | 24.8% | 71.3% |
Diluted EPS [+] | $1.64 | $4.45 | $5.18 | $3.52 | $4.26 | $3.18 | $3.72 | $2.99 |
Growth | -63.1% | -13.9% | 47.1% | -17.3% | 33.7% | -14.4% | 24.2% | 71.6% |
|
Dividends per share [+] | $1.46 | $1.31 | $1.22 | $1.14 | $1.03 | $0.94 | $0.89 | $0.79 |
Growth | 11.5% | 7.4% | 7.0% | 10.7% | 9.6% | 5.6% | 12.7% | 12.9% |
|
Shares outstanding (basic) [+] | 42.6 | 43.0 | 42.9 | 42.7 | 42.6 | 42.7 | 43.0 | 44.2 |
Growth | -0.9% | 0.2% | 0.5% | 0.2% | -0.2% | -0.7% | -2.7% | -1.1% |
Shares outstanding (diluted) [+] | 42.9 | 43.4 | 43.2 | 43.2 | 43.0 | 43.0 | 43.3 | 44.3 |
Growth | -1.2% | 0.5% | 0.0% | 0.5% | 0.0% | -0.7% | -2.3% | -1.3% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|